- $9.72m
- $11.91m
- $5.98m
- 55
- 30
- 24
- 29
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.9 | 6.07 | 4.74 | 7.05 | 5.98 |
Cost of Revenue | |||||
Gross Profit | 0.452 | 1.59 | 1.03 | 1.4 | 1.01 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9.57 | 8.15 | 8.65 | 10.3 | 9.38 |
Operating Profit | -3.67 | -2.09 | -3.92 | -3.2 | -3.4 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.56 | -0.547 | -2.86 | -2.73 | -2.69 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.56 | -0.547 | -2.86 | -2.73 | -2.69 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3.56 | -0.544 | -2.85 | -2.74 | -2.69 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.56 | -0.544 | -2.85 | -2.74 | -2.69 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.08 | -0.309 | -0.75 | -0.65 | -0.551 |